GPR120/FFAR4 stimulation attenuates airway remodeling and suppresses IL-4- and IL-13-induced airway epithelial injury via inhibition of STAT6 and Akt
Open Access
- 2 November 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 168, 115774
Abstract
No abstract availableKeywords
Funding Information
- Mahidol University
This publication has 74 references indexed in Scilit:
- Different Effects of Farrerol on an OVA-Induced Allergic Asthma and LPS-induced Acute Lung InjuryPLOS ONE, 2012
- Defective epithelial barrier function in asthmaJournal of Allergy and Clinical Immunology, 2011
- Expression of IL-4/IL-13 receptors in differentiating human airway epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- Interleukin-13 Induces Mucin 5AC Production Involving STAT6/SPDEF in Human Airway Epithelial CellsCell Communication & Adhesion, 2010
- The Role of the Epithelium in Airway Remodeling in AsthmaProceedings of the American Thoracic Society, 2009
- Thymic stromal lymphopoietin is a critical mediator of IL‐13‐driven allergic inflammationEuropean Journal of Immunology, 2009
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsJournal of Experimental Medicine, 2007
- Airway remodeling contributes to the progressive loss of lung function in asthma: An overviewJournal of Allergy and Clinical Immunology, 2005
- Airway remodeling in asthma: New insightsJournal of Allergy and Clinical Immunology, 2003